Sarah Dickinson
Family · Wyoming, MINPI 1174091730
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.2%), food and beverage and consulting fees — rather than concentrated in one kind of arrangement. 6 manufacturers reported payments, led by Kerecis Limited at 45.2% of the total. 2025 is the largest year on record at $2,014, more than ten times the $117 reported in 2021.
Across 28 payments — averaging $114.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kerecis Limited$1K
- Organogenesis Inc.$1K
- Boehringer Ingelheim$585
- Smith+Nephew$36
- Urgo Medical North America, LLC$35
- Mimedx Group, Inc.$27
What the payments were for
- Consulting fees$58518%
- Travel & lodging$1,48546%
- Food & beverage$1,14336%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kerecis Limited | 9 | $1,452 |
| Organogenesis Inc. | 14 | $1,078 |
| Boehringer Ingelheim | 1 | $585 |
| Smith+Nephew | 2 | $36 |
| Urgo Medical North America, LLC | 1 | $35 |
| Mimedx Group, Inc. | 1 | $27 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Kerecis SurgiClose$5,330
- Kerecis GraftGuide$1,332
- SPEVIGO$585
- PURAPLY WOUND MATRIX$430
- Apligraf$430
- NuShield$430
- NOVACHOR$430
- Affinity$430
- PuraPly$123
How this compares
$3,213 in reported general payments places this provider in the 85th percentile of 3,657 family providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gentamicin Sulfate | 21 | $714 |
| Clotrimazole | 11 | $674 |
| Doxycycline Hyclate | 26 | $158 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 19 | $107 |
| Cephalexin | 13 | $58 |
| Triamcinolone Acetonide | 14 | $56 |
| Levofloxacin | 15 | $36 |
Paid to pharmacies, not to this prescriber.
Other family in Wyoming
- Heather RhodesWyoming$13K
- Jayme HeimGrandville$663K
- Susan WolgamottBloomfield Township$327K
- Elisheva EllenbergDetroit$150K
- Sarah JohnsonFarmington Hills$119K
- Daniela MaximTroy$112K
- Kelsey PrinceGrand Rapids$87K
- Brent MillerFremont$66K
- Rachael CompeauFlint$62K
- David KocendaLapeer$49K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.